These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29625171)

  • 1. The role of nitric oxide (NO) donors in anxiety. Lights and shadows.
    Pitsikas N
    Nitric Oxide; 2018 Jul; 77():6-11. PubMed ID: 29625171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nitric oxide donors in schizophrenia: Basic studies and clinical applications.
    Pitsikas N
    Eur J Pharmacol; 2015 Nov; 766():106-13. PubMed ID: 26435027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows.
    Zoupa E; Pitsikas N
    Molecules; 2021 May; 26(11):. PubMed ID: 34073534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric Oxide (NO) Synthase Inhibitors: Potential Candidates for the Treatment of Anxiety Disorders?
    Pitsikas N
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38543047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Nitric Oxide Donors With Therapeutic Potential.
    Buca BR; Mititelu-Tarţau L; Lupuşoru RV; Popa GE; Rezuş C; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):942-6. PubMed ID: 30141891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric Oxide and Anxiety.
    Gulati K; Rai N; Ray A
    Vitam Horm; 2017; 103():169-192. PubMed ID: 28061970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide donors: novel cancer therapeutics (review).
    Huerta S; Chilka S; Bonavida B
    Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide-dependent pathways in ethanol-induced anxiolytic effects in rats.
    Ferreira VM; Valenzuela CF; Morato GS
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1898-904. PubMed ID: 10630608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications for nitric oxide in halting proliferation of tumor cells.
    Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
    Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and repeated exposure with the nitric oxide (NO) donor sodium nitroprusside (SNP) differentially modulate responses in a rat model of anxiety.
    Orfanidou MA; Lafioniatis A; Trevlopoulou A; Touzlatzi N; Pitsikas N
    Nitric Oxide; 2017 Sep; 69():56-60. PubMed ID: 28522342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
    Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
    Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in the study of nitric oxide-donating drugs].
    Zhang YH; Peng SX
    Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.
    Trevlopoulou A; Touzlatzi N; Pitsikas N
    Psychopharmacology (Berl); 2016 Mar; 233(6):1045-54. PubMed ID: 26685991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
    Seabra AB; Durán N
    Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric Oxide. V. therapeutic potential of nitric oxide donors and inhibitors.
    Muscará MN; Wallace JL
    Am J Physiol; 1999 Jun; 276(6):G1313-6. PubMed ID: 10362633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.
    Seabra AB; de Lima R; Calderón M
    Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety.
    Kalouda T; Pitsikas N
    Pharmacol Biochem Behav; 2015 Nov; 138():111-6. PubMed ID: 26363313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide donors for peripheral artery disease.
    Falconer D; Papageorgiou N; Salem K; Lim WY; Katsargyris A; Avgerinos E; Tousoulis D
    Curr Opin Pharmacol; 2018 Apr; 39():77-85. PubMed ID: 29587164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxocobalamins as biologically compatible donors of nitric oxide implicated in the acceleration of wound healing.
    Bauer JA
    Med Hypotheses; 1998 Jul; 51(1):65-7. PubMed ID: 9881839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze.
    Calixto AV; Duarte FS; Duzzioni M; Nascimento Häckl LP; Faria MS; De Lima TC
    Behav Brain Res; 2010 Feb; 207(1):112-7. PubMed ID: 19800925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.